Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BID | P55957 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.40 |
| ▸ | TACR2 | P21452 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5269764 | 0.98 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5270426 | 0.98 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5271614 | 0.98 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5269201 | 0.98 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL3235877 | 0.98 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5272182 | 0.98 | BID (0.44) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL6222946 | 0.94 | TYR (0.39) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL9359701 | 0.86 | CNR1 (0.35) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL9756310 | 0.83 | CA2 (0.33) | — | |
| SCHEMBL16719748 | 0.81 | CA2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023182327-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, ORGANIC EL DISPLAY DEVICE, AND METHOD FOR PRODUCING CURED PRODUCT | 東レ株式会社 | 2023-09-28 | — | — | WO | disclosed |
| CN-115698854-A | Photosensitive resin composition, cured product, display device, semiconductor device, and method for producing cured product | 东丽株式会社 | 2023-02-03 | — | — | CN | disclosed |
| CN-111742246-B | Antireflection film and multilayer film having antireflection film | 三菱瓦斯化学株式会社 | 2022-06-17 | — | — | CN | disclosed |
| CN-113574420-A | Laminate for antireflection film, and method for producing laminate for antireflection film | 三菱瓦斯化学株式会社 | 2021-10-29 | — | — | CN | disclosed |
| CN-113302035-A | Antireflection film and multilayer film having antireflection film | 三菱瓦斯化学株式会社 | 2021-08-24 | — | — | CN | disclosed |
| WO-2021140927-A1 | RETARDATION FILM AND APPLICATIONS THEREOF | 大阪ガスケミカル株式会社 | 2021-07-15 | — | — | WO | disclosed |
| WO-2021131942-A1 | FLUORENE DERIVATIVE, METHOD FOR PRODUCING SAME, AND APPLICATION OF SAME | 大阪ガスケミカル株式会社 | 2021-07-01 | — | — | WO | disclosed |
| WO-2020213470-A1 | DICARBOXYLIC ACIDS, AND PRODUCTION METHOD AND USE THEREOF | 大阪ガスケミカル株式会社 | 2020-10-22 | — | — | WO | disclosed |
| CN-111742246-A | Antireflection film and multilayer film having antireflection film | 三菱瓦斯化学株式会社 | 2020-10-02 | — | — | CN | disclosed |
| US-20040024209-A1 | 1-Aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | SCHNUTE MARK E (US) | 2004-02-05 | — | — | US | disclosed |
| US-6653307-B2 | Such as N-(4-chlorobenzyl)-6-(4-morpholinylmethyl)-4-oxo-1-phenyl-1,4-dihydro-3-quinolinecarboxamide for treatment of herpes virus; viral DNA polymerase inhibitors | PHARMACIA & UPJOHN COMPANY | 2003-11-25 | — | — | US | disclosed |
| EP-1292575-A2 | 1-ARYL-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2003-03-19 | — | — | EP | disclosed |
| US-20020103220-A1 | 1-Aryl-4oxo-1,4-Dihydro-3-quinolinecarboxamides as antiviral agents | PHARMACIA & UPJOHN COMPANY | 2002-08-01 | — | — | US | disclosed |
| WO-2001098275-A2 | 1-ARYL-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXAMIDES AS ANTIVIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-0457730-B1 | Process for preparation of thioderivatives of alkylhydroxyanilinotriazine | CIBA GEIGY AG (CH) | 1994-11-09 | — | — | EP | disclosed |
| US-5086173-A | Hydrogenating in presence of palladium catalyst without isolating the intermediates | CIBA-GEIGY CORPORATION (US) | 1992-02-04 | — | — | US | disclosed |
| EP-0457730-A2 | Process for preparation of thioderivatives of alkylhydroxyanilinotriazine | CIBA-GEIGY AG (CH) | 1991-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024209-A1 | 1-Aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | ZC3HAV1, ZC3HAV1L, IRF3 | BID 923/4885MCL1 448/4885BCL2L1 321/4885 |
| US-20020103220-A1 | 1-Aryl-4oxo-1,4-Dihydro-3-quinolinecarboxamides as antiviral agents | ZC3HAV1, IRF3, ZC3HAV1L | BID 1239/4885MCL1 540/4885BCL2L1 444/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.